登录

Nanyan Insurtech Completes ¥100M Series B2 Funding

作者: Mailman 2020-02-04 17:17
南燕保险科技
http://www.ssish.com
企业数据由 动脉橙 提供支持
第三方保险电子商务综合服务提供商 | C轮 | 运营中
中国-上海
2020-10-15
融资金额:RMB¥2.5亿
千骥资本
查看

According to VCBeat, Nanyan Insurtech has completed its Series B2 round of financing, landing over a hundred million yuan, led by BOC International ("BOCI"), with participation from existing investors Bluerun Ventures, Savannah Industries Global Capital Group ("SIG") and Starr Companies. Phoenixtree Capital continued to serve as the exclusive financial consultant.


Proceeds of this financing are mainly used for the merger and acquisition of Medilink Global, a third-party service company specializing in the management of health insurance, and the layout of high-end medical insurance services including direct payment. 


Previously, Nanyan Insurtech closed three round of funding: a US15 million Series B+ round in November 2018 led by Starr Companies – global leading insurance and financial services organization, a tens of millions of dollars Series B round of financing led by SIG in December 2017, and a Series A led by Bluerun Ventures in 2016.


Founded in September 2015, Nanyan Insurtech provides both cost, service efficient, and risk control solutions – including product, sales, management and claims – for insurance companies, reinsurers and intermediaries by leveraging the capabilities in AI and big data.


Based on its proprietary technology, Nanyan Insurtech has built a SaaS platform covering product design, trading system and Enterprise resource planning (ERP) with completely digital management and monitoring. The company helps more than 1,000 insurance companies and insurance intermediaries including Ping An Insurance, American International Group ("AIG"), etc., covering an annual premium of nearly 1.5 billion yuan, settling more than 200,000 policies per month and accounting for about 30% of the market.


>>>>

About BOCI


BOCI, which specializes in investment banking, is a wholly-owned subsidiary of Bank of China Ltd. BOCI has created an organizational framework with an effective integrated management system. BOCI is well-positioned to offer its clients a wide range of investment banking services, including securities underwriting, mergers & acquisitions, financial advisory, equity sales & trading, equity derivatives, fixed income, asset management, private equity investments and global commodities.


>>>>

About Bluerun Ventures

BlueRun Ventures is an early-stage venture capital firm with offices in the United States, Shanghai, Beijing, and Korea. The company invests in technology-led companies that are pushing their industries forward, founders that believe in the problem and believe they can build the company and the team around them to make it happen.

相关赛道 商业保险
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

The Jordan Company收购医疗信息技术领导者Vyne,为美国数千家医疗机构提供信息服务

【2023投资风向标】对话远毅资本:数字医疗五大发展趋势显现,2023年要“谨慎地乐观”

Meditrust Health Closes ¥1B Series B Financing

Fussen Snares $14M in Series C Round, Focusing on Digital Dental Ecology Platform

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Launca Medical Snags ¥10M in Series B Round

2020-02-04
下一篇

【生物医药日报】钟南山:相关疫苗距临床应用尚需时间;佐剂型单价甲型流感疫苗Audenz获FDA批准上市

2020-02-04